The strategic investment will help ensure all key Novartis medicines for U.S. patients are manufactured in the U.S. and delivered to patients across the country at scale.
Upperton is a UK-based CDMO providing integrated contract development and manufacturing services. Specializing in oral, nasal, pulmonary and sterile dosage forms, Upperton offers a comprehensive range of services designed to support the progression of a molecule from early feasibility through to formulation development, clinical trial manufacture and commercial manufacture.
